StockData
Champions Oncology, Inc. logo

Champions Oncology, Inc. (CSBR) income statement

CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30238% above fair value
$4.44−0.15 (-3.30%)

Close on Nov 18, 2026Market cap $61.80MP/E –Yield –

Champions Oncology, Inc. income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin
49.8%
Operating margin
-1.7%
Net margin
-1.8%
Return on equity, FY2026
-30.5%

Financial strength

Current ratio
1.03
Debt to equity
–
Debt to assets
–
Cash to current liabilities
23.3%

Valuation

P/E ratio
–
Price to sales
1.02
Price to book
15.87
Dividend yield
–

See a number that looks wrong?